Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

Why Humana (HUM) Stock Is Up Today

September 02, 2025 at 15:35 PM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

HUM Cover Image

What Happened?

Shares of health insurance company Humana (NYSE: HUM) jumped 1.8% in the afternoon session after Bank of America Securities raised its price target for the company. The firm maintained its "Neutral" rating on Humana but increased its price target to $312 from $285, representing a potential 9.5% upside from the previous target. This analyst action follows other recent positive developments for the healthcare company. In late August, Humana announced new value-based care partnerships with Vori Health and HOPCo. These partnerships are aimed at expanding individualized musculoskeletal care for its Medicare Advantage members, signaling continued efforts to enhance its service offerings.

After the initial pop the shares cooled down to $309.83, up 2% from previous close.

Is now the time to buy Humana? Access our full analysis report here, it’s free.

What Is The Market Telling Us

Humana’s shares are quite volatile and have had 15 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 5 months ago when the stock dropped 15.3% on the news that peer UnitedHealth reported underwhelming first-quarter 2025 results as its sales and profits fell below Wall Street expectations. Guidance was the biggest concern. The new full-year earnings forecast came in well below what analysts had been expecting, mainly because the company saw its care (medical costs in its privately run Medicare plans) and funding issues lasting longer. The news cast a shadow over other health insurers with similar offerings, hinting at tighter margins and more uncertainty ahead.

Humana is up 22.6% since the beginning of the year, but at $309.83 per share, it is still trading 16.6% below its 52-week high of $371.40 from September 2024. Investors who bought $1,000 worth of Humana’s shares 5 years ago would now be looking at an investment worth $724.29.

Do you want to know what moves the business you care about? Add them to your StockStory watchlist and every time a stock significantly moves, we provide you with a timely explanation straight to your inbox. It’s free and will only take you a second.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article